KROS Keros Therapeutics, Inc. - common stock
$10,15
Prix · Mai 20, 2026
Données fondamentales au Mai 14, 2026
Fourchette 52 semaines
$10–$23
3% of range
Note des analystes
BUY
15 analysts
Objectif de cours
$22
+115% upside
P/E (TTM)
8.9
ROE
17.2%
Marge nette
35.7%
KROS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$10.15
Capitalisation Boursière
$398M
P/E (TTM)
8.9
BPA (TTM)
$2.30
Revenus (TTM)
$244M
Rendement div.
—
ROE
17.2%
Dette/Capitaux propres
—
Fourchette 52 semaines
$10 – $23
KROS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$244M
2019-12-31
→
2025-12-31
BPA
$2.30
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$106M
2020-12-31
→
2025-12-31
Marges
35.7%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
KROS
Médiane des pairs
P/E (TTM)
8.9
2.4
P/S (TTM)
1.6
15.2
P/B
1.3
1.4
Price / FCF (Cours / FCF)
3.8
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
KROS
Médiane des pairs
Operating Margin (Marge d'exploitation)
27.7%
—
Net Profit Margin (Marge nette)
35.7%
-946.2%
ROA
18.2%
-52.8%
ROE
17.2%
-60.2%
ROIC
21.1%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
KROS
Médiane des pairs
Current Ratio (Ratio de liquidité)
15.5
7.4
Quick Ratio (Ratio de liquidité réduite)
14.3
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
KROS
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
KROS
Médiane des pairs
KROS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
15 analystes
- Achat fort 4 26,7%
- Achat 6 40,0%
- Conserver 5 33,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
6 analystes · 2026-05-19
Médiane
$20.00
Moyenne
$21.83
← En dessous de tous les objectifs
$10.15
Bas
$16.00
Haut
$30.00
Objectif médian
$20.00
+97,0%
Objectif moyen
$21.83
+115,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.95%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-1.21 | $-1.04 | -0.17% |
| 31 décembre 2025 | $-0.86 | $-0.64 | -0.22% |
| 30 septembre 2025 | $-0.18 | $-1.07 | 0.89% |
| 30 juin 2025 | $-0.76 | $-1.15 | 0.39% |
| 31 mars 2025 | $3.62 | $-0.25 | 3.9% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| BDTX | $139M | 6.2 | — | 31.9% | 18.3% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| HUMA | — | — | — | — | — | — |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $0 | $151.0K | $0 | $20M | $0 | $10M | |
| R&D Expense | $130M | $174M | $135M | $87M | $55M | $34M | $17M | |
| SG&A Expense | $47M | $41M | $35M | $28M | $21M | $13M | $3M | |
| Operating Expenses | $176M | $214M | $170M | $115M | $76M | $47M | $21M | |
| Operating Income | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | $-11M | |
| Other Non-op | $-539.0K | $-954.0K | $-206.0K | $-613.0K | $-383.0K | $160.0K | $241.0K | |
| Pretax Income | $92M | $-187M | $-153M | $-105M | $-57M | $-46M | $-12M | |
| Income Tax | $5M | $300.0K | $0 | $0 | $2M | $-172.0K | $0 | |
| Net Income | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | $-12M | |
| EPS (Basic) | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| EPS (Diluted) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| Shares (Basic) | 37,221,211 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| Shares (Diluted) | 37,859,106 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| EBITDA | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | · |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $287M | $560M | $331M | $279M | $230M | $266M | $7M | |
| Receivables | $4M | $3M | $143.0K | $0 | $18M | $0 | · | |
| Prepaid Expense | $22M | $26M | $16M | $7M | $3M | $2M | $381.0K | |
| Other Current Assets | $2M | $1M | $1M | $276.0K | $210.0K | $160.0K | $215.0K | |
| Current Assets | $315M | $589M | $347M | $286M | $251M | $268M | $9M | |
| PP&E (Net) | $4M | $4M | $4M | $2M | $1M | $724.0K | $708.0K | |
| PP&E (Gross) | $9M | $7M | $6M | $3M | $2M | $1M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $846.0K | $721.0K | $453.0K | |
| Other Non-current Assets | $0 | $2M | $2M | $2M | $82.0K | $0 | · | |
| Total Assets | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Accounts Payable | $2M | $5M | $5M | $3M | $4M | $2M | $2M | |
| Accrued Liabilities | $16M | $21M | $18M | $13M | $7M | $5M | $2M | |
| Current Liabilities | $20M | $27M | $24M | $17M | $12M | $7M | $4M | |
| Capital Leases | $14M | $17M | $13M | $13M | $231.0K | $476.0K | $899.0K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $62.0K | $119.0K | |
| Total Liabilities | $35M | $44M | $38M | $29M | $12M | $8M | $10M | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $1.17B | $1.14B | $714M | $506M | $367M | $327M | $203.0K | |
| Retained Earnings | $-482M | $-569M | $-381M | $-228M | $-124M | $-65M | $-20M | |
| Treasury Stock | $385M | $0 | · | · | · | · | · | |
| Stockholders' Equity | $303M | $572M | $332M | $277M | $243M | $262M | $-19M | |
| Liabilities + Equity | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Shares Outstanding | 19,543,706 | 40,554,705 | 31,841,084 | 27,543,453 | 23,974,834 | 23,192,866 | 2,429,705 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $29M | $35M | $29M | $19M | $12M | $4M | $59.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $108M | $-161M | $-125M | $-70M | $-62M | $-37M | $-16M | |
| CapEx | $2M | $2M | $2M | $1M | $1M | $294.0K | $271.0K | |
| Investing Cash Flow | $-2M | $-2M | $-2M | $-1M | $-1M | $-294.0K | $-271.0K | |
| Stock Issued | · | · | · | · | · | $141M | $0 | |
| Stock Repurchased | $375M | $0 | · | · | · | · | · | |
| Net Stock Activity | $-375M | · | · | · | · | $141M | · | |
| Financing Cash Flow | $-378M | $392M | $179M | $120M | $29M | $296M | $14.0K | |
| Net Change in Cash | $-273M | $229M | $52M | $49M | $-35M | $259M | $-16M | |
| Taxes Paid | $7M | $0 | · | · | · | $0 | $256.0K | |
| Free Cash Flow | $106M | $-163M | $-127M | $-71M | $-63M | $-37M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| Net Margin | 35.7% | -5277.6% | -101319.2% | · | -292.3% | · | · | |
| Pretax Margin | 37.7% | -5269.1% | -101319.2% | · | -282.2% | · | · | |
| EBITDA Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| ROA | 18.2% | -38.0% | -45.2% | -37.2% | -22.4% | -32.4% | · | |
| ROE | 17.2% | -33.9% | -48.7% | -40.4% | -25.4% | -23.1% | · | |
| ROIC | 21.1% | -37.0% | -51.1% | -41.4% | -24.0% | -17.8% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 | 37.3 | · | |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 | 37.0 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · | |
| Receivables Turnover | 77.3 | 2.5 | 2.1 | 0.0 | 2.2 | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $244M | $0 | $151.0K | $0 | $20M | $0 | · | |
| Net Income TTM | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | · | |
| Market Cap | $398M | $642M | $1.27B | $1.32B | $1.40B | $1.64B | · | |
| P/E | 8.9 | -3.2 | -7.6 | -11.6 | -23.2 | -24.1 | · | |
| P/S | 1.6 | · | 8384.1 | · | 69.8 | · | · | |
| P/B | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Tangible Book | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Cash Flow | 3.7 | -4.0 | -10.2 | -18.9 | -22.6 | -44.3 | · | |
| P / FCF | 3.8 | -3.9 | -10.0 | -18.5 | -22.2 | -44.0 | · | |
| Earnings Yield | 11.3% | -31.6% | -13.1% | -8.6% | -4.3% | -4.2% | · |
Compte de résultat 14
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.0K | $380.0K | $14M | $18M | $211M | $0 | $0 | $0 | $0 | $143.0K | $8.0K | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $16M | $18M | $20M | $44M | $49M | $46M | $49M | $41M | $38M | $37M | $34M | $33M | $31M | $25M | $21M | $23M | |
| SG&A Expense | $10M | $12M | $10M | $14M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $7M | $7M | $7M | |
| Operating Expenses | $26M | $30M | $30M | $58M | $59M | $56M | $59M | $50M | $49M | $47M | $43M | $41M | $39M | $32M | $28M | $31M | |
| Operating Income | $-26M | $-29M | $-15M | $-40M | $152M | $-53M | $-59M | $-50M | $-48M | $-46M | $-43M | $-41M | $-39M | $-32M | $-28M | $-31M | |
| Other Non-op | $-166.0K | $273.0K | $-253.0K | $-221.0K | $-338.0K | $-229.0K | $-92.0K | $-196.0K | $-437.0K | $56.0K | $-67.0K | $-155.0K | $-40.0K | $-1M | $762.0K | $86.0K | |
| Pretax Income | $-24M | $-25M | $-9M | $-33M | $158M | $-46M | $-53M | $-45M | $-43M | · | · | · | · | $-30M | $-24M | $-27M | |
| Income Tax | $0 | $-2M | $-1M | $-2M | $10M | $300.0K | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | |
| Net Income | $-24M | $-23M | $-7M | $-31M | $148M | $-46M | $-53M | $-45M | $-43M | $-40M | $-39M | $-38M | $-36M | $-30M | $-24M | $-27M | |
| EPS (Basic) | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.66 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | $-1.13 | |
| EPS (Diluted) | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.62 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | $-1.13 | |
| Shares (Basic) | 19,629,906 | -84,574,415 | 40,623,364 | 40,612,907 | 40,559,355 | -71,941,684 | 37,590,727 | 36,103,187 | 35,685,422 | -58,193,039 | 29,668,247 | 29,602,458 | 28,369,453 | -48,356,346 | 25,549,701 | 24,053,977 | |
| Shares (Diluted) | 19,629,906 | -84,398,490 | 40,623,364 | 40,612,907 | 41,021,325 | -71,941,684 | 37,590,727 | 36,103,187 | 35,685,422 | -58,193,039 | 29,668,247 | 29,602,458 | 28,369,453 | -48,356,346 | 25,549,701 | 24,053,977 | |
| EBITDA | $-26M | · | $-15M | $-40M | $152M | · | $-59M | $-50M | $-48M | · | $-43M | $-41M | $-39M | · | $-28M | $-31M |
Bilan 22
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $281M | $287M | $693M | $690M | $721M | $560M | $531M | $406M | $442M | $331M | $288M | $322M | $351M | $279M | $239M | $216M | |
| Receivables | $400.0K | $4M | $3M | $16M | $17M | $3M | $388.0K | $4.0K | $226.0K | $143.0K | · | · | · | · | $0 | $0 | |
| Prepaid Expense | $7M | $22M | $22M | $27M | $22M | $26M | $21M | $27M | $20M | $16M | $17M | $12M | $11M | · | $6M | $7M | |
| Other Current Assets | $1M | $2M | $3M | $3M | $3M | $1M | $1M | $582.0K | $616.0K | $1M | $319.0K | $376.0K | $515.0K | · | $745.0K | $466.0K | |
| Current Assets | $291M | $315M | $719M | $733M | $760M | $589M | $552M | $433M | $463M | $347M | $304M | $334M | $362M | · | $246M | $222M | |
| PP&E (Net) | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | · | $2M | $2M | |
| PP&E (Gross) | · | $9M | · | · | · | $7M | · | · | · | $6M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $4M | · | · | · | $3M | · | · | · | $2M | · | · | · | · | · | · | |
| Other Non-current Assets | · | $0 | $0 | $0 | $463.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $3M | $667.0K | |
| Total Assets | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | $227M | |
| Accounts Payable | $1M | $2M | $2M | $5M | $7M | $5M | $5M | $7M | $5M | $5M | $4M | $4M | $5M | · | $3M | $8M | |
| Accrued Liabilities | $9M | $16M | $15M | $20M | $17M | $21M | $22M | $14M | $13M | $18M | $12M | $12M | $11M | · | $8M | $7M | |
| Current Liabilities | $13M | $20M | $24M | $35M | $39M | $27M | $29M | $21M | $19M | $24M | $17M | $16M | $15M | · | $12M | $15M | |
| Capital Leases | $14M | $14M | $15M | $16M | $16M | $17M | $17M | $13M | $13M | $13M | $14M | $14M | $14M | · | $0 | $0 | |
| Total Liabilities | $27M | $35M | $39M | $50M | $56M | $44M | $46M | $34M | $32M | $38M | $30M | $30M | $29M | · | $12M | $15M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | $2.0K | $2.0K | |
| Paid-in Capital | $1.18B | $1.17B | $1.16B | $1.16B | $1.15B | $1.14B | $1.06B | $891M | $878M | $714M | $637M | $628M | $619M | · | $440M | $386M | |
| Retained Earnings | $-505M | $-482M | $-458M | $-451M | $-420M | $-569M | $-523M | $-470M | $-425M | $-381M | $-341M | $-302M | $-264M | · | $-199M | $-175M | |
| Treasury Stock | $385M | $385M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $286M | $303M | $704M | $707M | $729M | $572M | $533M | $421M | $454M | $332M | $296M | $326M | $355M | $277M | $241M | $211M | |
| Liabilities + Equity | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | $227M | |
| Shares Outstanding | 19,732,837 | 19,543,706 | 40,632,164 | 40,615,414 | 40,562,047 | 40,554,705 | 39,258,476 | 36,169,558 | 36,067,786 | 31,841,084 | 29,679,143 | 29,661,005 | 29,548,649 | · | 26,077,204 | 24,429,382 |
Flux de trésorerie 9
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $7M | $4M | $9M | $9M | $9M | $9M | $9M | $8M | $7M | $9M | $7M | $6M | $5M | $5M | $5M | |
| Operating Cash Flow | $-4M | $-27M | $3M | $-30M | $161M | $-46M | $-30M | $-40M | $-45M | $-25M | $-34M | $-31M | $-34M | $-21M | $-25M | $-23M | |
| CapEx | $73.0K | $134.0K | $132.0K | $720.0K | $565.0K | $289.0K | $386.0K | $310.0K | $946.0K | $541.0K | $550.0K | $311.0K | $1M | $351.0K | $176.0K | $567.0K | |
| Investing Cash Flow | $-73.0K | $-134.0K | $-132.0K | $-720.0K | $-565.0K | $-289.0K | $-386.0K | $-310.0K | $-946.0K | $-541.0K | $-550.0K | $-311.0K | $-1M | $-351.0K | $-176.0K | $-567.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | $151M | · | $0 | $0 | $107M | · | $48M | $10M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $151M | · | · | · | $107M | · | · | · | |
| Financing Cash Flow | $-2M | $-379M | $140.0K | $17.0K | $4.0K | $76M | $156M | $4M | $157M | $69M | $284.0K | $2M | $108M | $61M | $49M | $10M | |
| Net Change in Cash | $-6M | $-406M | $3M | $-30M | $161M | $29M | $125M | $-37M | $111M | $43M | $-34M | $-29M | $72M | $40M | $24M | $-13M | |
| Free Cash Flow | $-4M | · | · | · | $161M | · | · | · | $-46M | · | · | · | $-35M | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | · | |
| Net Margin | -74087.5% | · | -51.5% | -169.0% | 70.3% | · | -13648.4% | -122316.2% | -51944.6% | · | -493000.0% | · | · | · | · | · | |
| Pretax Margin | -74087.5% | · | -61.6% | -181.2% | 75.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | · | |
| ROA | -4.3% | · | -1.1% | -5.1% | 23.4% | · | -11.7% | -11.2% | -9.9% | · | -13.6% | -12.9% | -11.6% | · | -9.7% | -11.6% | |
| ROE | -4.7% | · | -1.2% | -5.4% | 25.1% | · | -12.8% | -12.1% | -10.7% | · | -14.7% | -14.0% | -12.4% | · | -10.2% | -12.2% | |
| ROIC | -9.1% | · | -1.8% | -5.2% | 19.5% | · | · | · | · | · | · | · | · | · | -11.6% | -14.5% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.6 | · | 29.9 | 21.1 | 19.3 | · | 19.0 | 20.4 | 24.7 | · | 18.2 | 20.8 | 23.4 | · | 21.3 | 14.4 | |
| Quick Ratio | 21.9 | · | 28.9 | 20.3 | 18.7 | · | 18.3 | 19.1 | 23.6 | · | 17.2 | 20.0 | 22.7 | · | 20.8 | 14.0 |
Efficacité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | 0.0 | · | 7.3 | 2.3 | 24.1 | · | 2.0 | 18.5 | 0.7 | · | · | · | · | · | · | 0.0 |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $244M | · | $243M | $229M | $211M | · | $8.0K | $8.0K | $8.0K | · | $8.0K | $0 | · | · | · | · | |
| Net Income TTM | $87M | · | $58M | $20M | $7M | · | $-181M | $-165M | $-156M | · | $-136M | $-124M | $-111M | · | $-95M | $-87M | |
| Market Cap | $218M | · | $643M | $542M | $413M | · | $2.28B | $1.65B | $2.39B | · | $946M | $1.19B | $1.26B | · | $981M | $675M | |
| P/E | 7.5 | · | 12.5 | 66.8 | -40.8 | · | -11.2 | -9.0 | -13.1 | · | -6.7 | -8.8 | -9.9 | · | -9.6 | -7.5 | |
| P/S | 0.9 | · | 2.6 | 2.4 | 2.0 | · | 284967.5 | 206618.6 | 298460.9 | · | 118271.4 | · | · | · | · | · | |
| P/B | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | 3.2 | |
| P / Tangible Book | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | 3.2 | |
| P / Cash Flow | -61.7 | · | · | · | 2.6 | · | · | · | -53.6 | · | · | · | -36.9 | · | · | · | |
| P / FCF | -60.5 | · | · | · | 2.6 | · | · | · | -52.5 | · | · | · | -35.7 | · | · | · | |
| Earnings Yield | 13.3% | · | 8.0% | 1.5% | -2.5% | · | -8.9% | -11.1% | -7.7% | · | -15.0% | -11.4% | -10.1% | · | -10.4% | -13.3% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $244M | $0 | $151.0K | $0 | $20M |
| Marge d'exploitation % | 27.7% | -5939.0% | -112543.7% | — | -280.5% |
| Résultat net | $87M | $-187M | $-153M | $-105M | $-59M |
| BPA dilué | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 |
| Ratio de liquidité réduite | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $106M | $-163M | $-127M | $-71M | $-63M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.